+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vertex Pharmaceuticals Inc.  - logo

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines. Founded in 1989 in Cambridge, MA, Vertex has research and development sites and commercial offices around the world in the United States, Canada, Europe and Australia. In May 2011, the U.S. Food and Drug Administration (FDA) approved Vertex’s first medicine, a treatment for hepatitis C. In 2012, Vertex received approval for our medicine for cystic fibrosis in the U.S., Europe and Canada. Vertex received Australian approval of our medicine for cystic fibrosis in 2013.

Global Hepatitis C Drugs Market 2021-2025 - Product Thumbnail Image

Global Hepatitis C Drugs Market 2021-2025

  • Report
  • January 2021
  • 120 Pages
From
From
From
mRNA: Therapeutics and Global Markets 2021-2026 - Product Thumbnail Image

mRNA: Therapeutics and Global Markets 2021-2026

  • Report
  • September 2021
  • 271 Pages
From
From
From
From
From
From
Hepatitis C - Pipeline Review, H2 2020 - Product Thumbnail Image

Hepatitis C - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 426 Pages
From
Loading Indicator